These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 29921039

  • 1. Identification of new biophysical markers for pathological ventricular remodelling in tachycardia-induced dilated cardiomyopathy.
    Benitez-Amaro A, Samouillan V, Jorge E, Dandurand J, Nasarre L, de Gonzalo-Calvo D, Bornachea O, Amoros-Figueras G, Lacabanne C, Vilades D, Leta R, Carreras F, Gallardo A, Lerma E, Cinca J, Guerra JM, Llorente-Cortés V.
    J Cell Mol Med; 2018 Sep; 22(9):4197-4208. PubMed ID: 29921039
    [Abstract] [Full Text] [Related]

  • 2. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V, Matteucci M, Ribezzo M, Di Silvestre D, Brambilla F, Agostini S, Mauri P, Padeletti L, Pingitore A, Delsedime L, Rinaldi M, Recchia FA, Pucci A.
    J Cell Mol Med; 2014 Mar; 18(3):396-414. PubMed ID: 24444256
    [Abstract] [Full Text] [Related]

  • 3. Analysis of DCM associated protein alterations of human right and left ventricles.
    Ameling S, Bischof J, Dörr M, Könemann S, Empen K, Weitmann K, Klingel K, Beug D, Dhople VM, Völker U, Hammer E, Felix SB.
    J Proteomics; 2021 Jan 16; 231():104018. PubMed ID: 33075551
    [Abstract] [Full Text] [Related]

  • 4. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K, Miyagawa S, Fukushima S, Saito A, Sakai Y, Ueno T, Sawa Y.
    J Thorac Cardiovasc Surg; 2013 Dec 16; 146(6):1516-25. PubMed ID: 24229503
    [Abstract] [Full Text] [Related]

  • 5. Pathophysiology and pathological remodelling associated with dilated cardiomyopathy in broiler chickens predisposed to heart pump failure.
    Olkowski AA, Wojnarowicz C, Laarveld B.
    Avian Pathol; 2020 Oct 16; 49(5):428-439. PubMed ID: 32301624
    [Abstract] [Full Text] [Related]

  • 6. Biophysical and Lipidomic Biomarkers of Cardiac Remodeling Post-Myocardial Infarction in Humans.
    Samouillan V, Martinez de Lejarza Samper IM, Amaro AB, Vilades D, Dandurand J, Casas J, Jorge E, de Gonzalo Calvo D, Gallardo A, Lerma E, Ramos JMG, Carreras F, Leta R, Llorente Cortes V.
    Biomolecules; 2020 Oct 22; 10(11):. PubMed ID: 33105904
    [Abstract] [Full Text] [Related]

  • 7. Transcriptomic Signatures of End-Stage Human Dilated Cardiomyopathy Hearts with and without Left Ventricular Assist Device Support.
    Parikh M, Shah S, Basu R, Famulski KS, Kim D, Mullen JC, Halloran PF, Oudit GY.
    Int J Mol Sci; 2022 Feb 12; 23(4):. PubMed ID: 35216165
    [Abstract] [Full Text] [Related]

  • 8. Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning.
    Maack C, Dabew ER, Hohl M, Schäfers HJ, Böhm M.
    Circ Res; 2009 Oct 09; 105(8):811-7. PubMed ID: 19729596
    [Abstract] [Full Text] [Related]

  • 9. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T, Naya M, Manabe O, Wakasa S, Kubota S, Chiba S, Iwano H, Yamada S, Yoshinaga K, Tamaki N, Tsutsui H, Matsui Y.
    JACC Cardiovasc Imaging; 2011 Jul 09; 4(7):762-70. PubMed ID: 21757167
    [Abstract] [Full Text] [Related]

  • 10. Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy.
    Yokokawa T, Sugano Y, Nakayama T, Nagai T, Matsuyama TA, Ohta-Ogo K, Ikeda Y, Ishibashi-Ueda H, Nakatani T, Yasuda S, Takeishi Y, Ogawa H, Anzai T.
    Eur J Heart Fail; 2016 Apr 09; 18(4):375-85. PubMed ID: 26763891
    [Abstract] [Full Text] [Related]

  • 11. Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure.
    Böhm M, Eschenhagen T, Gierschik P, Larisch K, Lensche H, Mende U, Schmitz W, Schnabel P, Scholz H, Steinfath M.
    J Mol Cell Cardiol; 1994 Feb 09; 26(2):133-49. PubMed ID: 8006975
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.
    Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Moriguchi Y, Shibasaki Y, Kamihata H, Inada M, Iwasaka T.
    Circ Res; 1998 Nov 16; 83(10):1035-46. PubMed ID: 9815151
    [Abstract] [Full Text] [Related]

  • 13. Can right ventricular endomyocardial biopsy predict left ventricular fibrosis beforehand in dilated cardiomyopathy?
    Amemiya K, Matsuyama TA, Ishibashi-Ueda H, Morita Y, Matsumoto M, Ohta-Ogo K, Ikeda Y, Tsukamoto Y, Fukushima N, Fukushima S, Fujita T, Hatakeyama K.
    ESC Heart Fail; 2024 Apr 16; 11(2):1001-1008. PubMed ID: 38234242
    [Abstract] [Full Text] [Related]

  • 14. Right and left ventricular geometry and myocyte contractile processes with dilated cardiomyopathy: myocyte growth and beta-adrenergic responsiveness.
    McMahon WS, Mukherjee R, Gillette PC, Crawford FA, Spinale FG.
    Cardiovasc Res; 1996 Feb 16; 31(2):314-23. PubMed ID: 8730409
    [Abstract] [Full Text] [Related]

  • 15. Right ventricular morphology and function is not related with microRNAs and fibrosis markers in dilated cardiomyopathy.
    Rubiś P, Totoń-Żurańska J, Wiśniowska-Śmiałek S, Kołton-Wróż M, Wołkow P, Wypasek E, Rudnicka-Sosin L, Pawlak A, Kozanecki K, Tomkiewicz-Pająk L, Podolec P.
    Cardiol J; 2018 Feb 16; 25(6):722-731. PubMed ID: 28840590
    [Abstract] [Full Text] [Related]

  • 16. Cellular and molecular mechanisms of systolic and diastolic dysfunction in an avian model of dilated cardiomyopathy.
    Wu Y, Tobias AH, Bell K, Barry W, Helmes M, Trombitas K, Tucker R, Campbell KB, Granzier HL.
    J Mol Cell Cardiol; 2004 Jul 16; 37(1):111-9. PubMed ID: 15242741
    [Abstract] [Full Text] [Related]

  • 17. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts.
    Makarenko I, Opitz CA, Leake MC, Neagoe C, Kulke M, Gwathmey JK, del Monte F, Hajjar RJ, Linke WA.
    Circ Res; 2004 Oct 01; 95(7):708-16. PubMed ID: 15345656
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts.
    Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ.
    Mol Cell Biochem; 1996 Feb 09; 155(1):13-21. PubMed ID: 8717434
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of atrial fibrosis in patients with dilated cardiomyopathy.
    Ohtani K, Yutani C, Nagata S, Koretsune Y, Hori M, Kamada T.
    J Am Coll Cardiol; 1995 Apr 09; 25(5):1162-9. PubMed ID: 7897130
    [Abstract] [Full Text] [Related]

  • 20. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy.
    Schwartzkopff B, Fassbach M, Pelzer B, Brehm M, Strauer BE.
    Eur J Heart Fail; 2002 Aug 09; 4(4):439-4. PubMed ID: 12167381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.